Skip to main content
Back
Watch Compare

Burning Rock Biotech Ltd

Data quality: 100%
BNR
NASDAQ Services Health Services
$15.85
▼ $0.41 (-2.49%)
Mkt Cap: 176.79 M
Price
$16.42
Mkt Cap
176.79 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Revenue grew 1.77% annually over 5 years — modest growth
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -13.38 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 8.41%
Capital efficient — spends only 1.05% of revenue on capex

Growth

Revenue Growth (5Y)
1.77%
Below sector avg (3.99%)
Revenue (1Y)-6.64%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-50.57%
Below sector avg (-15.97%)
ROIC-39.86%
Net Margin-67.20%
Op. Margin-69.32%

Safety

Debt / Equity
0.00
Below sector avg (0.39)
Current Ratio4.07
Interest CoverageN/A

Valuation

PE (TTM)
-3.72
Below sector avg (-1.18)
P/B Ratio0.83
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Services sector median (515 peers)
Metric Stock Sector Median
P/E -3.7 -1.2
P/B 0.8 1.4
ROE % -50.6 -16.0
Net Margin % -67.2 -18.7
Rev Growth 5Y % 1.8 4.0
D/E 0.0 0.4

Analyst Price Target

No analyst coverage available

Earnings Estimates

No forward estimates available

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q12023 -$13.90 -$18.10 -30.2%
Q42022 -$19.00 -$21.10 -11.1%
Q32022 -$18.80 -$23.30 -23.9%
Q22022 -$18.50 -$25.00 -35.1%

ETFs Holding This Stock

BAHAX BAHAX
2.40% weight
BAFHX BAFHX
2.40% weight
YAFIX YAFIX
1.26% weight
YAFFX YAFFX
1.26% weight
TBGVX TBGVX
0.88% weight
TWEBX TWEBX
0.84% weight
YFSIX YFSIX
0.66% weight
YFSNX YFSNX
0.66% weight
FGM logo FGM First Trust Germany AlphaDEX Fund
0.65% weight
RFEU RFEU
0.53% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -6.64% Revenue Growth (3Y) -6.98%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 1.77% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 70.67 M Net Income (TTM) -47.49 M
ROE -50.57% ROA -35.47%
Gross Margin 70.25% Operating Margin -69.32%
Net Margin -67.20% Free Cash Flow (TTM) -13.38 M
ROIC -39.86% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.00 Current Ratio 4.07
Interest Coverage N/A Asset Turnover 0.53
Working Capital 164.77 M Tangible Book Value 213.33 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -3.72 Forward P/E N/A
P/B Ratio 0.83 P/S Ratio 2.50
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -7.57%
Market Cap 176.79 M Enterprise Value 5.66 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 6.56
FCF / Share -1.24 OCF / Share -1.17
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1.05% FCF Conversion 28.18%
SBC-Adj. FCF -34.70 M Growth Momentum -8.41

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 70.67 M 75.70 M 81.66 M 79.69 M 65.89 M
Net Income -47.49 M -92.07 M -140.82 M -125.02 M -62.41 M
EPS (Diluted) — — — — —
Gross Profit 49.65 M 51.16 M 55.10 M 57.14 M 48.11 M
Operating Income -48.99 M -94.27 M -142.15 M -125.08 M -63.21 M
EBITDA — — — — —
R&D Expenses 31.82 M 48.88 M 61.17 M 57.73 M 40.45 M
SG&A Expenses — — — — —
D&A 7.15 M 18.79 M 17.99 M 7.50 M 5.11 M
Interest Expense 0.0 0.0 15,000.0 241,000.0 102,000.0
Income Tax 806,000.0 336,000.0 288,000.0 141,000.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 121.29 M 146.48 M 230.16 M 357.56 M 408.13 M
Total Liabilities 41.71 M 38.25 M 62.22 M 67.99 M 37.09 M
Shareholders' Equity 79.57 M 108.23 M 167.94 M 289.57 M 371.04 M
Total Debt — — 0.0 372,000.0 1.13 M
Cash & Equivalents 71.22 M 86.63 M 131.28 M 224.61 M 290.47 M
Current Assets 106.40 M 124.52 M 182.50 M 285.75 M 386.77 M
Current Liabilities 36.48 M 37.10 M 59.66 M 58.41 M 37.02 M